ResMed (RMD) director Form 4: 38 shares for taxes at $250.1
ResMed Inc. (RMD) filed a Form 4 reporting a routine insider transaction by director Harjit Gill.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
ResMed Inc. (RMD) filed a Form 4 reporting a routine insider transaction by director Harjit Gill. On 11/11/2025, 38.209 shares of ResMed common stock were disposed of under transaction code F at a $250.1 price to cover taxes upon vesting of previously granted RSUs. Following this withholding event, Gill beneficially owns 9,867 shares, held directly. The filing notes the RSUs were originally granted on 11/20/2024. This reflects administrative tax withholding rather than an open‑market sale.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise Price or Tax Liability | ResMed Common Stock | 38.209 | $250.10 | $10K |
Footnotes (1)
- F1. Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/20/2024.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did ResMed (RMD) disclose in this Form 4?
Who is the reporting person and their role at ResMed (RMD)?
What does transaction code F mean in this context?
When were the RSUs originally granted?
AI-generated analysis. How Rhea-AI works. Not financial advice.